Evaluation of the poly(ADP-ribose) polymerase-1 gene variants in Alzheimer's disease
✍ Scribed by Hsin-Ping Liu; Wei-Yong Lin; Bor-Tsang Wu; Shu-Hsiang Liu; Wen-Fu Wang; Chon-Haw Tsai; Chun-Cheng Lee; Fuu-Jen Tsai
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 99 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0887-8013
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Amyloid peptide is thought to play a critical role in neuronal death in Alzheimer's disease (AD), most likely through oxidative stress. Free radical‐related injury leads to DNA breaks, which subsequently activates the repair enzyme poly(ADP‐ribose) polymerase‐1 (PARP‐1). In this study, the relationship between genetic variants situated at the PARP‐1 gene and AD development was investigated. We performed a case and control study from a Taiwanese population enrolled 120 AD patients and 111 healthy controls by using a polymerase chain reaction restriction fragment length polymorphism approach for two PARP‐1 exonic polymorphisms, 414C/T (rs1805404) and 2456T/C (rs1136410), corresponding to protein residues at positions 81Asp/Asp and762Val/Ala. There were no significant differences in allele or genotype frequencies for either PARP‐1 gene variant between the case and control groups; however, upon analysis of the haplotype distribution, four haplotypes (Hts) were identified. We found that the distributions of Ht3‐TT and Ht4‐CC were significantly associated with an increased risk of AD (P<0.0001), whereas the Ht1‐TC haplotype showed a protective effect for cases compared with the control group (P<0.05). These results reveal that the PARP‐1 gene is highly associated with AD susceptibility and might contribute to a critical mechanism that mediates cell survival or death as a response to cytotoxic stress. J. Clin. Lab. Anal. 24:182–186, 2010. © 2010 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract ## Background Adeno‐associated virus type 2 (AAV) has the ability to target integration of its DNA into a specific locus of the human genome. Site‐specific AAV integration is mediated by viral Rep proteins, although the role of cellular factors involved in this process is largely unkno